title: Does chloroquine contribute to the risk of serious adverse reactions to fansidar?
authors.forename: L
authors.initials: L
authors.lastname: Rombo
authors.forename: J
authors.initials: J
authors.lastname: Stenbeck
authors.forename: H O
authors.initials: HO
authors.lastname: Lobel
authors.forename: C C
authors.initials: CC
authors.lastname: Campbell
authors.forename: M
authors.initials: M
authors.lastname: Papaioanou
authors.forename: K D
authors.initials: KD
authors.lastname: Miller
mesh_terms: D002738:Chloroquine / Q000009:adverse effects*; D004338:Drug Combinations / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006801:Humans; D008288:Malaria / Q000517:prevention & control*; D011739:Pyrimethamine / Q000009:adverse effects*; D012871:Skin Diseases / Q000139:chemically induced; D013413:Sulfadoxine / Q000009:adverse effects*; D013424:Sulfanilamides / Q000009:adverse effects*
chemical_list: D004338:Drug Combinations; D013424:Sulfanilamides; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D002738:Chloroquine; D011739:Pyrimethamine